✦ LIBER ✦

Phase II Study of Mitomycin, Doxorubicin, and Cisplatin in the Treatment of Advanced Uterine Leiomyosarcoma: A Gynecologic Oncology Group Study

✍ Scribed by John H. Edmonson; John A. Blessing; Jonathan A. Cosin; David Scott Miller; David E. Cohn; Jacob Rotmensch

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of dacarbazine, mitomycin

✍ Harry J. Long III; John A. Blessing; Joel Sorosky 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 85 KB

A phase II evaluation of trabectedin in

✍ Bradley J. Monk; John A. Blessing; Daron G. Street; Carolyn Y. Muller; James J. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 292 KB

Ifosfamide and Doxorubicin in the Treatm

✍ Gregory Sutton; John A. Blessing; John H. Malfetano 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Sunitinib malate in the treatment of rec

✍ Martee L. Hensley; Michael W. Sill; Dennis R. Scribner Jr.; Jubilee Brown; Rober 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Phase II evaluation of liposomal doxorub

✍ Gregory Sutton; John Blessing; Parviz Hanjani; Paul Kramer 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Phase II study of a combination of mitom

✍ John H. Edmonson; Harry J. Long; Ronald L. Richardson; Edward T. Creagan; Stepha 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 216 KB